Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-118947
Filing Date
2025-12-05
Accepted
2025-12-05 17:29:42
Documents
12

Document Format Files

Seq Description Document Type Size
1 424B5 tm2532720-2_424b5.htm 424B5 538139
2 EX-FILING FEES tm2532720d2_ex-filingfees.htm   iXBRL EX-FILING FEES 22895
3 GRAPHIC lg_capricor-4c.jpg GRAPHIC 19299
  Complete submission text file 0001104659-25-118947.txt   690612

Data Files

Seq Description Document Type Size
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2532720d2_ex-filingfees_htm.xml XML 2627
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-290179 | Film No.: 251554005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)